Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

In t(8;21)(q22;q22) acute myeloid leukemia, the prognostic value of early minimal residual disease assessed with real-time quantitative polymerase chain reaction is the most important prognostic factor, but how long-term minimal residual disease monitoring may contribute to drive individual patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Willekens, Christophe, Blanchet, Odile, Renneville, Aline, Cornillet-Lefebvre, Pascale, Pautas, Cécile, Guieze, Romain, Ifrah, Norbert, Dombret, Hervé, Jourdan, Eric, Preudhomme, Claude, Boissel, Nicolas
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4815724/
https://ncbi.nlm.nih.gov/pubmed/26635039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.131946
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars